IS6202A - Lyfjauppskriftir og aðferðir til að gefa morfín ínös - Google Patents

Lyfjauppskriftir og aðferðir til að gefa morfín ínös

Info

Publication number
IS6202A
IS6202A IS6202A IS6202A IS6202A IS 6202 A IS6202 A IS 6202A IS 6202 A IS6202 A IS 6202A IS 6202 A IS6202 A IS 6202A IS 6202 A IS6202 A IS 6202A
Authority
IS
Iceland
Prior art keywords
noses
recipes
pharmaceutical
methods
administering morphine
Prior art date
Application number
IS6202A
Other languages
English (en)
Inventor
G. Achari Raja
R. Behl Charanjit
C. Demeireles Jorge
Dua Ramneik
D. Romeo Vincent (l βtinn)
Original Assignee
Nastech Pharmaceutical Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nastech Pharmaceutical Co. Inc. filed Critical Nastech Pharmaceutical Co. Inc.
Publication of IS6202A publication Critical patent/IS6202A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Otolaryngology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IS6202A 1999-06-16 2001-12-14 Lyfjauppskriftir og aðferðir til að gefa morfín ínös IS6202A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33453799A 1999-06-16 1999-06-16
PCT/US2000/014157 WO2000076506A1 (en) 1999-06-16 2000-05-23 Pharmaceutical formulations and methods comprising intranasal morphine

Publications (1)

Publication Number Publication Date
IS6202A true IS6202A (is) 2001-12-14

Family

ID=23307687

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6202A IS6202A (is) 1999-06-16 2001-12-14 Lyfjauppskriftir og aðferðir til að gefa morfín ínös

Country Status (30)

Country Link
US (1) US6677346B1 (is)
EP (2) EP1183027A4 (is)
JP (1) JP2003501467A (is)
KR (1) KR20020016831A (is)
AU (1) AU774175B2 (is)
BG (1) BG106221A (is)
BR (1) BR0012082A (is)
CA (1) CA2374877C (is)
CZ (1) CZ20014399A3 (is)
DE (1) DE10084709T1 (is)
DK (1) DK200101859A (is)
EE (1) EE200100677A (is)
ES (1) ES2197792B1 (is)
FI (1) FI20012462L (is)
GB (1) GB2367005A (is)
HR (1) HRP20010926A2 (is)
HU (1) HUP0201856A3 (is)
IS (1) IS6202A (is)
LT (1) LT4976B (is)
LU (1) LU90859B1 (is)
LV (1) LV12859B (is)
MX (1) MXPA01012879A (is)
NO (1) NO20015931L (is)
NZ (1) NZ515783A (is)
PL (1) PL352556A1 (is)
SE (1) SE0104203D0 (is)
SI (1) SI20850A (is)
SK (1) SK18172001A3 (is)
TR (1) TR200103613T2 (is)
WO (1) WO2000076506A1 (is)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9924797D0 (en) 1999-10-20 1999-12-22 West Pharm Serv Drug Res Ltd Compound
US20040115133A1 (en) * 2000-05-10 2004-06-17 Wermeling Daniel P. Intranasal opioid compositions
US20060083691A1 (en) * 2000-05-10 2006-04-20 Wermeling Daniel P Intranasal opioid compositions, delivery devices and methods of using same
EP1328214A4 (en) * 2000-09-20 2009-07-29 Shahinian Lee Jr NASAL, INHALABLE AND LOCAL OPHTHALMIC PREPARATIONS AND MEDICATIONS WITH SPONTANEOUS CONSERVATION
AU2002303148A1 (en) * 2001-06-29 2003-03-03 Leon J. Lewandowski Individualized addiction cessation therapy
GB0210264D0 (en) * 2002-05-03 2002-06-12 Arakis Ltd The treatment of pain and migraine headache
US20040102476A1 (en) * 2002-11-25 2004-05-27 Chan Tai Wah High concentration formulations of opioids and opioid derivatives
US20050175679A1 (en) * 2004-02-10 2005-08-11 Michael Moshman Controlled release formulations
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
US20140162965A1 (en) 2004-08-25 2014-06-12 Aegis Therapeutics, Inc. Compositions for oral drug administration
PL2377557T3 (pl) 2004-11-24 2017-05-31 Meda Pharmaceuticals Inc. Kompozycje zawierające azelastynę i sposoby ich zastosowania
US9415034B2 (en) * 2005-01-05 2016-08-16 National Defense Medical Center Inhibitors and enhancers of uridine diphosphate-glucuronosyltransferase 2B (UGT2B)
ES2277743B2 (es) 2005-06-02 2008-12-16 Universidade De Santiago De Compostela Nanoparticulas que comprenden quitosano y ciclodextrina.
JP2009506076A (ja) 2005-08-26 2009-02-12 ザ・ボード・オブ・トラスティーズ・オブ・ザ・レランド・スタンフォード・ジュニア・ユニバーシティ 三叉神経疼痛のための薬物送達のための治療手順
US20070212307A1 (en) * 2006-02-10 2007-09-13 Daniel Wermeling Pharmaceutical Compositions Comprising an Opioid Receptor Antagonist and Methods of Using Same
US8226949B2 (en) 2006-06-23 2012-07-24 Aegis Therapeutics Llc Stabilizing alkylglycoside compositions and methods thereof
CA2667072C (en) * 2006-12-22 2015-11-24 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Gel useful for the delivery of ophthalmic drugs
GB2477545B (en) * 2010-02-05 2011-12-21 Special Products Ltd A liquid morphine composition for buccal administration
NO2706982T3 (is) 2011-05-13 2018-06-02
WO2014016653A1 (en) 2012-07-26 2014-01-30 Wockhardt Limited Pharmaceutical composition comprising diamorphine for intranasal administration
EP3082817A4 (en) * 2013-12-18 2017-06-21 Aegis Therapeutics, LLC Compositions for drug administration
US11135155B2 (en) 2014-07-08 2021-10-05 Hikma Pharmaceuticals Usa Inc. Liquid naloxone spray
RS65034B1 (sr) 2015-01-07 2024-02-29 Tonix Pharma Ltd Formulacije oksitocina koje sadrže magnezijum i postupci za njihovu upotrebu
RS66592B1 (sr) 2016-04-12 2025-04-30 Tonix Pharma Ltd Formulacije oksitocina koje sadrže magnezijum i postupci za njihovu primenu
US20180110725A1 (en) * 2016-10-21 2018-04-26 Somniferum Labs LLC Compositions, methods and kits for the safe inhaled delivery of targeted opioids for the treatment of pain and addiction
BR112020007808A2 (pt) * 2017-10-20 2020-10-20 Chiesi Farmaceutici S.P.A. formulações farmacêuticas que compreendem um agonista de receptor de opioide como ingrediente ativo, métodos de fabricação e usos terapêuticos destas
WO2019157099A1 (en) 2018-02-06 2019-08-15 Aegis Therapeutics, Llc Intranasal epinephrine formulations and methods for the treatment of disease
CN115804754A (zh) * 2022-12-16 2023-03-17 广州新济药业科技有限公司 吗啡鼻喷剂及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464378A (en) 1981-04-28 1984-08-07 University Of Kentucky Research Foundation Method of administering narcotic antagonists and analgesics and novel dosage forms containing same
US4464376A (en) 1982-07-22 1984-08-07 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same
GB8514665D0 (en) * 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
US5202128A (en) 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
GB9202464D0 (en) * 1992-02-05 1992-03-18 Danbiosyst Uk Composition for nasal administration
DE69434304T2 (de) * 1993-03-26 2005-12-29 Merkus, Franciscus Wilhelmus H.M. Pharmazeutische Zusammensetzungen zur intranasalen Verabreichung von Dihydroergotamin
GB9426102D0 (en) 1994-12-23 1995-02-22 Merck Sharp & Dohme Pharmacuetical compositions
US5874450A (en) * 1996-09-27 1999-02-23 Nastech Pharmaceutical Company, Inc. Intranasal formulations for promoting sleep and method of using the same

Also Published As

Publication number Publication date
NZ515783A (en) 2004-05-28
BG106221A (bg) 2002-08-30
SI20850A (sl) 2002-10-31
PL352556A1 (en) 2003-08-25
EP1183027A4 (en) 2003-02-05
NO20015931D0 (no) 2001-12-04
LV12859B (en) 2002-12-20
DK200101859A (da) 2001-12-12
EE200100677A (et) 2003-02-17
SK18172001A3 (sk) 2002-07-02
NO20015931L (no) 2002-02-08
CA2374877C (en) 2004-04-13
GB0128383D0 (en) 2002-01-16
AU5156100A (en) 2001-01-02
AU774175B2 (en) 2004-06-17
SE0104203L (sv) 2001-12-14
FI20012462A7 (fi) 2002-01-16
KR20020016831A (ko) 2002-03-06
CZ20014399A3 (cs) 2002-06-12
WO2000076506A1 (en) 2000-12-21
LT4976B (lt) 2002-12-30
HUP0201856A1 (en) 2002-09-28
LU90859B1 (en) 2002-01-24
SE0104203D0 (sv) 2001-12-14
BR0012082A (pt) 2002-05-07
TR200103613T2 (tr) 2004-08-23
JP2003501467A (ja) 2003-01-14
HRP20010926A2 (en) 2003-04-30
MXPA01012879A (es) 2003-06-24
EP1183027A1 (en) 2002-03-06
FI20012462L (fi) 2002-01-16
US6677346B1 (en) 2004-01-13
GB2367005A (en) 2002-03-27
ES2197792B1 (es) 2005-05-01
HUP0201856A3 (en) 2004-12-28
CA2374877A1 (en) 2000-12-21
ES2197792A1 (es) 2004-01-01
LT2001119A (en) 2002-07-25
DE10084709T1 (de) 2002-09-26
EP1419774A1 (en) 2004-05-19

Similar Documents

Publication Publication Date Title
IS6202A (is) Lyfjauppskriftir og aðferðir til að gefa morfín ínös
NO20021401D0 (no) Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
NO20002831D0 (no) Medikament i myk tablettform og fremgangsmÕter for fremstilling av dette
NO20016277L (no) Systemer og fremgangsmåter for aerolisering av farmasöytiske sammensetninger
NO20044192L (no) 17alfa-alkyl-17beta-oksy-ostratriener og farmasoytiske preparater
DK1117645T3 (da) Arylsubstituerede propanolaminderivater, fremgangsmåder til fremstilling deraf, lægemidler indeholdende disse forbindelser og anvendelse deraf
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
DK1400518T3 (da) Heterocycliske forbindelser og lægemidler
DE69935681D1 (de) Vorrichtungen zur Medikamentverabreichung
NO20016314L (no) Blandinger og fremgangsmåte for oljefeltapplikasjoner
DK1163227T3 (da) Bicykliske heterocykliske forbindelser, farmaceutiske præparater indeholdende disse forbindelser og fremgangsmåder til fremstilling deraf
NO20014013L (no) 16-halogen-epotilonderivater, fremgangsmåter for fremstilling av disse og farmasöytisk anvendelse av dem
IS6310A (is) Kínasólínafleiður til lækninga
NO20031152D0 (no) Befruktningshindrende fremgangsmåte og administrasjonsform for det samme
DK1372686T3 (da) Fremgangsmåder og sammensætninger til peptidsyntese
DK1233736T3 (da) Terapiapparat til punktvis stimulation
NO20023161D0 (no) Substituerte piperidiner, legemidler inneholdende disse forbindelser og fremgangsmåter for fremstilling av dem
DK1334717T3 (da) Farmaceutiske sammensætninger til oral og topisk administrering
NO20026212L (no) Forbindelse for medikamentavleveringssystem og fremgangsmåte for fremstilling av forbindelsen
DK1311731T3 (da) Fremgangsmåde og arrangement til stolpesystem
IS7266A (is) Lyfjaform sem innihalda sýru-óþolin virk efni og aðferðir til tilreiðslu þeirra
DK1054672T3 (da) Morfinsulfatmikrogranula, fremgangsmåde til fremstilling deraf og farmaceutiske præparater
DK0868911T3 (da) Rapamycinpræparater til oral indgivelse
IS7798A (is) Efnasambönd, lyfjablöndur og aðferðir
NO20042890L (no) Farmasoytiske preparater og fremgangsmate for fremstilling derav